Guindo Chirfi 4
4 · Merck & Co., Inc. · Filed Aug 6, 2024
Insider Transaction Report
Form 4
Guindo Chirfi
Chief Marketing Officer
Transactions
- Exercise/Conversion
Common Stock
2024-08-05$115.20/sh+36,901$4,250,995→ 57,781.593 total - Tax Payment
Common Stock
2024-08-05$115.20/sh−17,412$2,005,862→ 40,369.593 total - Exercise/Conversion
Restricted Stock Unit
2024-08-05−36,901→ 36,903 totalFrom: 2023-08-03Exp: 2025-08-03→ Common Stock (36,901 underlying)
Holdings
- 53.83(indirect: By 401(k))
Common Stock-401(k) Plan
Footnotes (4)
- [F1]Holdings include shares acquired in dividend reinvestment transactions.
- [F2]Includes shares acquired and dividends earned through July 8, 2024 in the Merck U.S. Savings Plan, a 401(k) plan.
- [F3]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- [F4]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 8/3/2023, 8/3/2024 and 8/3/2025 or, if such date is not a business day, the business day immediately thereafter.